EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I

Owen Leddy iD, Forest M White iD, Bryan D Bryson iD

eLife · 19.04.2023 · 12

DOI: 10.7554/elife.84070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 19.04.2023. Verfasst von Owen Leddy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States. Hauptthemen laut MEDLINE: Antigen Presentation, Mycobacterium tuberculosis. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIEHS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8+ T cell recognition of Mycobacterium tuberculosis ( Mtb )-specific peptides presented on major histocompatibility complex class I (MHC-I) contributes to immunity to tuberculosis (TB), but the principles that govern presentation of Mtb antigens on MHC-I are incompletely understood. In this study, mass spectrometry (MS) analysis of the MHC-I repertoire of Mtb -infected primary human macrophages reveals that substrates of Mtb ’s type VII secretion systems (T7SS) are overrepresented among Mtb -derived peptides presented on MHC-I. Quantitative, targeted MS shows that ESX-1 activity is required for presentation of Mtb peptides derived from both ESX-1 substrates and ESX-5 substrates on MHC-I, consistent with a model in which proteins secreted by multiple T7SSs access a cytosolic antigen processing pathway via ESX-1-mediated phagosome permeabilization. Chemical inhibition of proteasome activity, lysosomal acidification, or cysteine cathepsin activity did not block presentation of Mtb antigens on MHC-I, suggesting involvement of other proteolytic pathways or redundancy among multiple pathways. Our study identifies Mtb antigens presented on MHC-I that could serve as targets for TB vaccines, and reveals how the activity of multiple T7SSs interacts to contribute to presentation of Mtb antigens on MHC-I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigen PresentationMycobacterium tuberculosisHumansAntigens, BacterialHistocompatibility Antigens Class IPeptides

Stichwörter der Autor:innen

MHC-Iantigen presentationimmunologyinfectious diseaseinflammationm. tuberculosismacrophagesmicrobiologyphagosomesecretion systems

Substanzen

Mycobacterium tuberculosis antigensAntigens, BacterialHistocompatibility Antigens Class IPeptides

Autor:innen und Institutionen

  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States.
  • Ragon Institute of Massachusetts General Hospital, Harvard, and MIT, Cambridge, United States.
  • Koch Institute for Integrative Cancer Research, Cambridge, United States.
  • Center for Precision Cancer Medicine, Cambridge, United States.

ORCID-Profile: Owen Leddy, Forest M White, Bryan D Bryson

Förderung

  • NIGMS NIH HHS
  • NIEHS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Environmental Health Sciences
  • Center for Precision Cancer Medicine

Zitieren

APA

Leddy, O., White, F. M., & Bryson, B. D. (2023). Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I. eLife, 12. https://doi.org/10.7554/elife.84070

Vancouver

Leddy O, White FM, Bryson BD. Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I. eLife. 2023;12. doi:10.7554/elife.84070

BibTeX
@article{Leddy2023,
  author = {Leddy, Owen and White, Forest M and Bryson, Bryan D},
  title = {Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.84070}
}
Kostenlos starten →